Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

We evaluated the efficacy of metronomic etoposide or temozolomide administered with bevacizumab among recurrent glioblastoma (GBM) patients who progressed on prior bevacizumab therapy in a phase 2, open-label, two-arm trial. Twenty-three patients received bevacizumab (10 mg/kg) every 2 weeks with ei...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Reardon, David A., Desjardins, Annick, Peters, Katherine, Gururangan, Sridharan, Sampson, John, Rich, Jeremy N., McLendon, Roger, Herndon, James E., Marcello, Jennifer, Threatt, Stevie, Friedman, Allan H., Vredenburgh, James J., Friedman, Henry S.
格式: Artigo
語言:Inglês
出版: 2010
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3102515/
https://ncbi.nlm.nih.gov/pubmed/20853132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-010-0403-6
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍